Try our Advanced Search for more refined results
Alzheon, Inc. v. Risen (Suzhou) Pharma Tech Co., Ltd.
Case Number:
Case Type:
IPR
Status:
Final Written Decision
Petitioner:
Alzheon, Inc.
Patent Owner:
Risen (Suzhou) Pharma Tech Co., Ltd.
Tech Center:
1600
-
March 11, 2024
Fed. Circ. OKs Boston Drug Developer's Patent Win
A Boston-area biotech developer that has yet to bring a product to market persuaded the Federal Circuit on Monday to affirm a finding by an administrative patent board last year that stripped a smaller Chinese rival of a patent covering a way of using a type of sulfonic acid to potentially treat Alzheimer's disease.
-
July 13, 2022
Mass. Biotech Biz Gets PTAB To Wipe Alzheimer's Drug Patent
A panel of Patent Trial and Appeal Board judges has sided with arguments from Boston biotech developer Alzheon Inc. that the patent office never should have granted a patent to a smaller Chinese rival that covers a way of using a type of sulfonic acid to potentially treat Alzheimer's disease.
-
April 07, 2022
IP Forecast: Norton Fights Patent Suit, Armed With New Attys
The company behind Norton's AntiVirus brand of malware detection software has armed itself with some new BigLaw guns to defend against a nearly decade-old patent lawsuit that claims some of that software was actually developed by professors at Columbia University. Here's a look at that case — plus all the other major intellectual property matters facing the court in the coming week.
-
July 15, 2021
PTAB Will Review Alzheimer's Treatment Patent
The Patent Trial and Appeal Board has agreed to review a Chinese company's patent involving a treatment for Alzheimer's disease challenged by biotech firm Alzheon Inc.